Patient Home Monitoring (PHM-V) June 4, '14 has closed the acquisition of Care Medical Partners LLC, a profitable Georgia-based company focused on providing home-based chronic pulmonology services. The acquisition is expected to have an immediate and substantial impact on earnings-per-share (EPS) and is expected to increase total run-rate revenues of PHM to over $27 million annually.
Acquisition
PHM Post-Acquisition is expected to generate:
-- Over $27 million in annual run-rate revenue -- Over $5.75 million in annual run-rate EBITDA -- Significant new organic growth cross-selling opportunities designed to generate additional revenue and profit growth
Care Medical generated over $13.1 million in revenue for the period between March 31, 2013 and March 31, 2014, with just over $2 million in Adjusted EBITDA(1) over the same period, based upon final unaudited due diligence.
PHM paid $5,476,150 for the acquisition, which is equivalent to 2.72 times trailing 12-month unaudited Adjusted EBITDA(1), paid in cash, stock and acquisition of medical equipment leases.
Under the terms of the Definitive Purchase Agreement, PHM will acquire 100% of the units of Care Medical for a total consideration of (1) US $144,243.60 in cash to the sellers and (2) 5,655,476 shares of PHM issued to the sellers, subject to TSX approval. The sellers agreed to take PHM shares at a share value of US$0.26 per share or equivalent of approximately CAD$0.28 per share.
As part of the transaction, PHM will acquire $3.15 million in medical equipment placed with patients generating revenue through paying various leases and loans. PHM plans to secure additional debt financing in the near future with a focus to increase shareholder value for this and other medical equipment acquired to service patients.
"There is an immediate and positive EPS impact with this acquisition," said Michael Dalsin, Chairman and CEO of PHM. "While the acquisition will only be reflected in PHM's financial statements for the last month of the current quarter, I expect there to be a significant impact on this quarter's financial results with the full force of revenue and profits being recorded in this year's fiscal fourth quarter."
"Care Medical is a complimentary fit with our previous South Carolina acquisitions both in services offered and geographically," continued Mr. Dalsin. "With our latest acquisitions in Florida, South Carolina, and Georgia, we are solidifying PHM's regional presence in the southeastern United States while at the same time providing significant expansion opportunities for our California-based cardiology service business unit. While we were able to acquire this business at a favorable multiple, I expect our post integration multiple to be much lower. Andrew Folmer and the operational team plan to efficiently integrate the business into PHM and are focused on generating organic and cross-selling revenue immediately within the existing growing patient database."
"Our M&A team is nearing the LOI stage with two additional acquisition targets and I expect to have the next deal lined up shortly," Mr. Dalsin concluded. "We have plenty of cash and a solid balance sheet combined with strong positive cash flow, which puts PHM in a position to close these subsequent transactions without additional equity financing." |
